News Category
Quantum BioPharma announced FDA approval of its IND application for Lucid-MS, a first-in-class neuroprotective candidate for multiple sclerosis, allow...
PX1 Research's expansion of cGMP quality control and HPLC purity verification to all its US-manufactured research peptides provides academic and resea...
NanoViricides has received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 for Ebola in the DRC, potentially offering a mor...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth and metastasis in TNBC models, supporting ...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a significant step toward a potential neuroprotective therapy for mult...
Tonix Pharmaceuticals' Q2 2026 revenue surged to $13.5 million, led by TONMYA sales, marking a significant commercial milestone and providing cash run...
Tonix Pharmaceuticals' second-quarter revenue surged to $13.5 million, driven by strong sales of its fibromyalgia drug TONMYA, marking a significant c...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through key clinical, regulatory, and commercial stages, positionin...
Quantum BioPharma is advancing a two-pronged approach to neurological health, focusing on its MS therapy Lucid-MS and alcohol metabolism supplement un...
Quantum BioPharma is progressing its two-pronged approach to neurological health, advancing its MS therapy Lucid-MS and its alcohol metabolism supplem...
VERAXA Biotech's next-generation antibody platforms, including ADCs and T-cell engagers, position it to attract significant pharma investment and part...
A case in Spain where a patient's pork tapeworm infection mimicked brain cancer underscores the importance of proper food preparation and the need for...
VERAXA Biotech has advanced its VXA-222 bispecific ADC program beyond discovery and expanded its patent portfolio, strengthening its position in next-...
A new liquid biopsy offers a simpler way to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving treatment...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA vaccine, supporting the scheduled Q4 20...
Onco-Innovations is combining PNKP-targeted DDR inhibition, nanoparticle delivery, and causal AI to advance its lead candidate ONC010, potentially imp...
Researchers at Nagoya University discovered that the immune protein C3, when produced within tumors, can boost the effectiveness of immunotherapy, off...
VolitionRx's new Capture-Seq technology achieves >99% pure ctDNA isolation, potentially transforming cancer detection and monitoring, with implication...
Tonix Pharmaceuticals announced its participation in two upcoming investor conferences, highlighting its commitment to engaging with the investment co...
VERAXA Biotech announced the advancement of its VXA-222 bispecific antibody-drug conjugate program beyond the discovery phase, leveraging OmniAb's ant...
NeuroThera Labs has initiated its Phase IIb clinical trial at Yale Child Study Center, advancing a novel cannabinoid-based treatment for Tourette Synd...
SRX Global's investment in Vistagen Therapeutics highlights a strategic move to capitalize on undervalued neuroscience assets and potentially drive sh...
SRX Global's acquisition of a stake in Vistagen Therapeutics signals a strategic move to unlock shareholder value in an undervalued biopharmaceutical ...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital reaches halfway enrollment, showing promising preliminary data that cou...
Biotech Labz Supply Inc now offers 11 high-purity research peptides with batch-specific COA documentation, streamlining procurement for qualified labo...
Oncotelic Therapeutics will present at the OTCQB Virtual Investor Conference, showcasing significant advancements in its clinical trials and platform ...
Tonix Pharmaceuticals announced FDA feedback supporting an adaptive Phase 2 field study for its Lyme disease prevention candidate TNX-4800, marking a ...
Independent research suggests cross-reactive immune responses from licensed Ebola vaccines may extend to other ebolaviruses, reinforcing the strategic...
Regentis Biomaterials is progressing its GelrinC platform, which could address a significant unmet need in cartilage repair with a minimally invasive,...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital reaches halfway enrollment, with preliminary data suggesting a more pre...
NeuroThera Labs' quantum platform successfully processed real-world clinical data through an integrated hybrid quantum-classical workflow, marking a s...
NeuroOne released a white paper detailing how its StereoCED™ platform, designed for robotic-assisted multi-trajectory drug delivery, could address sca...
VERAXA Biotech has appointed antibody therapeutics specialist Dr. Christoph Erkel as Chief Scientific Officer to lead the advancement of its proprieta...
Onco-Innovations Limited has closed a CAD$5 million private placement with Sorbie Bornholm LP and Sorbie Investments LLP, with proceeds allocated to a...
Lexaria Bioscience Corp. will implement a 1-for-15 reverse stock split effective August 3, 2026, aiming to increase its share price above the $1.00 Na...
VolitionRx announces increasing body of peer-reviewed studies supporting its Nu.Q H3.1 test as a biomarker for sepsis, showing ability to distinguish ...
Instinct Bio announced a strategic collaboration with INVITRX to manufacture and sell GENREVER cosmetic products in the U.S. and supply materials for ...
Renaissance BioScience Corp. appoints Dr. James Tansey, a seasoned entrepreneur and academic, to its board to leverage his expertise in technology com...
Dr. Sven K. Weber, formerly Vice President of BASF's global enzyme business, will become CEO of BRAIN Biotech AG on October 1, 2026, succeeding Adriaa...
VERAXA Biotech announced an expansion of its intellectual property portfolio with new patent filings covering its BiTAC-TCE and BiTAC-ADC platforms, s...
MindBio Therapeutics has completed and delivered its first Edge AI Intoxication and Fatigue Detection Kiosk prototypes, using voice analysis AI to scr...
VERAXA Biotech strengthens its scientific leadership with the appointment of Dr. Christoph Erkel as CSO, signaling a strategic push to advance its BiT...
VERAXA Biotech AG filed new patent applications in early 2026 covering its BiTAC-TCE and BiTAC-ADC platforms, expanding its portfolio to over 50 grant...
Greenland Mines (NASDAQ: GRML) has been granted a Canadian patent for Klotho-based gene therapies targeting cognition, memory, and neurodegenerative d...
Quantum BioPharma's executive discusses the advancement of Lucid-MS for multiple sclerosis and the commercial potential of unbuzzd, highlighting the c...
VERAXA Biotech shareholders approved corporate governance and financing measures with over 99.94% support, aiming to enhance flexibility for acquisiti...
Greenland Mines Ltd. (NASDAQ: GRML) announced a Canadian patent for its Klotho-based gene therapy technology, covering treatments for Alzheimer's, Par...
NanoViricides has submitted an application to begin a Phase II trial of its oral antiviral NV-387 for Bundibugyo ebolavirus in the DRC, where no appro...
